FOIA to the National Institutes of Health seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the National Institute of Allergy and Infectious Diseases seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the Office of Management and Budget seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the Food and Drug Administration (FDA) seeking records sufficient to identify the date Gilead submitted its request for orphan-drug designation for remdesivir as a treatment for COVID-19.

FOIA to the U.S. Department of Health and Human Services (HHS) seeking communications with companies developing vaccines or treatments for coronavirus.

FOIA to the Food and Drug Administration seeking records sufficient to identify, with respect to requests for orphan-drug designation for treatments for COVID-19, the requester’s name, the date of the request, and the name of the treatment.

FOIA to the Food and Drug Administration (FDA) seeking communications with companies developing vaccines or treatments for coronavirus.